In the past few years or so, a wave of technological advancements is promising to take the world by storm, in the same way that the mobile internet redefined our lives ten years ago. In the world of AI, Atlas, the brainchild of Google and Softbank’s prodigy Pepper, as rudimentary as they may appear for the moment, portend exciting realities to come, while in the realm of biotechnology, the improvements over the past few years have been slightly more subtle. How can we expect AI and biotech to revamp our lives? These extraordinary individuals will offer their postulations.

Zhao Ruilin--Illumina China Country manager

Ruilin Zhao is the General Manager of Greater China at Illumina, Inc., which provides sequencing and array-based solutions for genetic analysis. Prior to joining Illumina, he was managing China Corporate Marketing and Commercial Operations for Thermo Fisher.  He had also been working at OrbusNeich as the VP of Finance, and at Microport as the company VP of Business Development and the General Manager of Endovascular Division.  He also worked as a product design engineer at Johnson & Johnson.  He holds a Ph.D. Degree in Medical Engineering and Medical Physics from the Harvard-MIT Division of Health Sciences and Technology and an MBA Degree from the Wharton Business School at the University of Pennsylvania.

Start your free trial now.

Get instant access to all our premium content, archives, newsletters, and online community.

Monthly Membership

Yearly Membership

What you get

Full access to all premium content and our full archives

Members'-only newsletters

Preferential access and discounts to all TechNode events

Direct access to the TechNode newsroom

Start your free trial now.

Get instant access to all our premium content, archives, newsletters, and online community.

Monthly Membership

Yearly Membership

April Ma

Based in Beijing, April Ma writes on tech trends and covers startups that may (or may not) be the next BATs. Reach her at April.ma@technode.com or Mafangjing (Wechat).